• Background provides appropriate perspective / context for the subject
• Objectives / research questions are clearly stated
• Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
• Data sources and/or sampling procedures are clear and appropriate
• Data analyses are appropriate
• Research objectives are met/addressed
• Implications of findings are discussed
• Factual information is kept separate from interpretations or implications
• Abstract is presented in an unbiased manner
• Clarity of presentation

A SPECIAL THANKS GOES TO Bradley Martin PharmD, PhD, RPh, Chair, ISPOR Contributed Research Paper Awards Committee -- Poster Presentations, AS WELL AS TO Fadia Shaya PhD, MPH, Chair, ISPOR Contributed Research Paper Awards Committee -- Podium Presentations, FOR ALL THEIR EFFORTS IN SELECTING THE WINNERS

THE RECIPIENTS  ARE: . . .

ISPOR Best Contributed Paper Awards Podium Presentations

Best General Podium Presentations

	CN3- 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA Reed SD, Anstrom KJ, Li Y, Schulman KA Duke Clinical Research Institute, Durham, NC, USA
	DB4-RETESTING OF HEMOGLOBIN A1C AFTER OUT-OF-RANGE RESULTS: CLINICAL PRACTICE VERSUS GUIDELINES Huse D, Bizier R, Durden ED Thomson Medstat, Cambridge, MA, USA
	MC1- METHODS OF MODEL CALIBRATION: A COMPARATIVE APPROACH Taylor DC1, Kruzikas D2, Pandya A1, Iskandar R1, Gilmore K1, Weinstein MC3 1i3 Innovus, Medford, MA, USA, 2GlaxoSmithKline, Philadelphia, PA, USA, 3Harvard University, Boston, MA, USA

Best New Investigator Podium Presentations

	AR3- CAUSES AND EFFECTS OF SCENARIO REJECTION: STATED PREFERENCES FOR RHEUMATOID ARTHRITIS TREATMENTS Ozdemir S1, Johnson FR1, Hauber B2, Bala M3 1Research Triangle Institute, Research Triangle Park, NC, USA, 2Research Triangle Institute, Doylestown, PA, USA, 3Johnson & Johnson, Malvern, PA, USA
	CV2- MEDICATION REFILL PERSISTENCE: DOES PRESCRIPTION COST-SHARING MATTER? Zhang D1, Carlson AM2, Gleason PP3, Schondelmeyer SW4, Schommer JC4, Dowd BE4, Heaton AH5 1IMS Health, Blue Bell, PA, USA, 2Data Intelligence Consultants LLC, Eden Prairie, MN, USA, 3Prime Therapeutics LLC, Eagan, MN, USA, 4University of Minnesota, Minneapolis, MN, USA, 5BlueCross BlueShield of Minnesota, Eagan, MN, USA
	PQ4- EVALUATION OF A MULTICENTER AND MULTIDISCIPLINARY CONGESTIVE HEART FAILURE MANAGEMENT PROGRAM Tan WS1, Heng BH2 1National Healthcare Group, Singapore, Singapore, 2National Healthcare Group, Singapore, Singapore

Best Student Podium Presentations

	PQ1- HOSPITAL COMPLIANCE WITH ACCP GUIDELINES FOR ANTICOAGULANT THERAPY AND JCAHO PERFORMANCE MEASURES Vats V1, Nutescu EA1, Theobald JC2, Wojtynek JE2, Schumock GT1 1University of Illinois at Chicago, Chicago, IL, USA, 2Consorta Inc, Schaumburg, IL, USA
	IN4- ECONOMIC EVALUATION OF INFLUENZA PANDEMIC MITIGATION STRATEGIES IN THE US USING A STOCHASTIC MICROSIMULATION INFLUENZA MODEL Sander B1, Nizam A2, Garrison LP3, Postma MJ4, Halloran ME3, Longini Jr IM3 1University of Toronto, Toronto, ON, Canada, 2Emory University, Atlanta, GA, USA, 3University of Washington, Seattle, WA, USA, 4University of Groningen, Groningen, The Netherlands
	AR4- METHODS FOR MEASURING DOSE ESCALATION IN TNF ANTAGONISTS FOR RHEUMATOID ARTHRITIS PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE Gu NY1, Huang X2, Globe D2, Fox KM3 1University of Southern California, Los Angeles, CA, USA, 2Amgen, Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC., Monkton, MD USA

ISPOR Best Contributed Paper Awards Poster Presentation

Best General Poster Presentations

	PMH24- 36-MONTH COST-UTILITY ANALYSIS OF ANTIPSYCHOTIC TREATMENTS IN PATIENTS WITH SCHIZOPHRENIA IN THE PAN-EUROPEAN SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY Windmeijer F1, Brown J2, Novick D2, Hong J3, Knapp M3, Kontodimas S2, Ratcliffe M2 1University of Bristol, Bristol, UK, 2Eli Lilly and Company Limited, Windlesham, Surrey, UK, 3London School of Economics, London, UK
	PHP22- HEALTH REIMBURSEMENT ACCOUNT BASED CONSUMER DRIVEN HEALTH PLANS:THEIR IMPACT ON MEDICAL UTILIZATION, PHARMACY UTILIZATION AND EXPENDITURES Nair K1, Park J2, Wolfe P1, Allen RR3, Saseen J1 1University of Colorado at Denver and the Health Sciences Center, Denver, CO, USA, 2GlaxoSmithKline, Research Triangle Park, NC, USA, 3Peak Statistical Services, Evergreen, CO, USA
	PCV35- IMPACT OF NESIRITIDE ON TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE (ADHF): EVIDENCE FROM A US HOSPITAL DATABASE DiDomenico R1, Sengupta N2, Barker C2 1University of Illinois at Chicago, Chicago, IL, USA, 2Scios Inc, Mountain View, CA, USA

	PHP8- RACIAL/ETHNIC DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AND OUT-OF-POCKET COSTS Bhandari A University of Maryland, School of Pharmacy, Baltimore, MD, USA
	PRS4- AN ECONOMIC EVALUATION OF FIRST LINE ANTIBIOTICS FOR THE INPATIENT TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS IN MEXICO Salinas-Escudero G1, Contreras-Hernandez I1, Mould-Quevedo J2, Davila-Loaiza G2 1Social Security Mexican Institute, Mexico City, Mexico, 2Pfizer Mexico, Mexico City, Mexico
	PHP39- QUALITY ASSESSMENT OF PHARMACOECONOMIC EVALUATIONS SUBMITTED FOR REIMBURSEMENT IN KOREA Lim SH, Kwon EY, Cho SC, Bae EY, Yi SY, Kim BY Health Insurance Review Agency, Seoul, South Korea

Best Student Poster Presentations

	PCV15- NEW DIAGNOSIS OF HYPERTENSION AMONG CELECOXIB AND NON-SELECTIVE NSAID USERS: A POPULATION-BASED COHORT STUDY Wang J1, Mullins CD1, Mamdani M2, Rublee DA2, Shaya FT1 1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2Pfizer, Inc, New York, NY, USA
	PCV56- THE COST-EFFECTIVENESS LANDSCAPE OF GENETIC TESTING WITH WARFARIN THERAPY Meckley LM1, Austin MJF2, Garrison LP1, Veenstra DL1 1University of Washington, Seattle, WA, USA, 2F. Hoffmann-La Roche AG, Basel, Switzerland
	PCV4 CUMULATIVE PERSISTENCE OF ANTIHYPERTENSIVE MEDICATION AS A NEWLY PRESCRIBED DRUG IN A MEDICAID POPULATION Gu A1, Shaya FT1, Weir MR2, 1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2University of Maryland, Baltimore, MD, USA